Heart failure & cardiomyopathiesCohort study

Longitudinal trajectories of albuminuria and risk of subclinical and clinical heart failure, atrial fibrillation, and coronary heart disease: the MESA study

Eur J Prev CardiolPublished

  • Prospective cohort study
  • latent class mixed modelling

Authors' conclusion

Progressive UACR increases identify individuals at elevated cardiovascular risk, particularly for HF.

Study context

Population
Multi-Ethnic Study of Atherosclerosis participants (mean age 61.7 years)10-year sample n = 4,343
Participants
5,581 participants
Exposure
Urine albumin-creatinine ratio (UACR) trajectory groups over 5 and 10 years
Outcome
Subclinical and clinical HF, HF subtypes, AF and CHD

Main finding

As reported in the abstract

HF, HF subtypes, composite of HF/death, AF and CHD

Sustained medium to high (5-year) and rapid rise (10-year) groups had higher risks of heart failure (HF), HF subtypes, HF/death, atrial fibrillation (AF) and coronary heart disease (CHD)

1.5- to 3.7-fold

Observational data: associations, not effects.

Further findings

HF, HFpEF, HFrEF after censoring for interim AF or CHD

Associations persisted for HF and HFpEF, but not HFrEF

N-terminal pro-brain natriuretic peptide (NT-proBNP), high-sensitivity troponin T (hs-TnT), native T1, extracellular volume fraction

Elevated in these trajectory groups

Original publication

Longitudinal trajectories of albuminuria and risk of subclinical and clinical heart failure, atrial fibrillation, and coronary heart disease: the MESA study. Eur J Prev Cardiol. Published 3 November 2025. doi:10.1093/eurjpc/zwaf699

Summarised from the published abstract; every number is checked against it